178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Program may help patients with rheumatic diseases quit smoking

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli
Study compares hospitalized infection risk for biologics in RA

Study compares hospitalized infection risk for biologics in RA

(HealthDay)—For patients with rheumatoid arthritis (RA) with prior biologic exposure, the risk of hospitalized infection is increased with etanercept, infliximab, and rituximab versus abatacept, accor

Study compares hospitalized infection risk for biologics in RA

(HealthDay)—For patients with rheumatoid arthritis (RA) with prior biologic exposure, the risk of hospitalized infection is increased with etanercept, infliximab, and rituximab versus abatacept, accor
CAR NKT cells offer a promising novel immunotherapy for solid tumors

CAR NKT cells offer a promising novel immunotherapy for solid tumors

by Molly Chiu,Baylor College of MedicineCredit: CC0 Public DomainNatural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have b

CAR NKT cells offer a promising novel immunotherapy for solid tumors

by Molly Chiu,Baylor College of MedicineCredit: CC0 Public DomainNatural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have b
Analysis of DNA reveals weapons used by our immune cells to fight tuberculosis

Analysis of DNA reveals weapons used by our immune cells to fight tuberculosis

by Agency for Science, Technology and Research (A*STAR), SingaporeFig. 1: Histone acetylome-wide association study of TB. Credit: DOI: 10.1038/s41564-021-01049-wA study led by the Agency for Scie

Analysis of DNA reveals weapons used by our immune cells to fight tuberculosis

by Agency for Science, Technology and Research (A*STAR), SingaporeFig. 1: Histone acetylome-wide association study of TB. Credit: DOI: 10.1038/s41564-021-01049-wA study led by the Agency for Scie
CAR-T therapy modifications provide new promise for cancer immunotherapies

CAR-T therapy modifications provide new promise for cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainNew research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company L

CAR-T therapy modifications provide new promise for cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainNew research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company L
Some cases of long COVID-19 may be caused by an abnormally suppressed immune system

Some cases of long COVID-19 may be caused by an abnormally suppressed immune system

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led team of researchers studying the effect of the monoclonal antibody Leronlimab on long COVID-19 may have found

Some cases of long COVID-19 may be caused by an abnormally suppressed immune system

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led team of researchers studying the effect of the monoclonal antibody Leronlimab on long COVID-19 may have found
Declining antibodies and immunity to COVID-19 – why the worry?

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di
'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

by Michelle Marchante, Miami HeraldThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

'New era and treatment of breast cancer': AI is helping detect breast cancer earlier

by Michelle Marchante, Miami HeraldThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom
COVID-19, MIS-C and Kawasaki disease share same immune response

COVID-19, MIS-C and Kawasaki disease share same immune response

by University of California - San DiegoUC San Diego researchers summarize the similarities and differences between COVID-19, MIS-C and Kawasaki disease, three conditions unified by the same immun

COVID-19, MIS-C and Kawasaki disease share same immune response

by University of California - San DiegoUC San Diego researchers summarize the similarities and differences between COVID-19, MIS-C and Kawasaki disease, three conditions unified by the same immun
Delivery methods compared for osteoarthritis intervention

Delivery methods compared for osteoarthritis intervention

First-line intervention for hip or knee osteoarthritis (OA) may reduce pain whether delivered in-person or digitally, according to a study published online Nov. 3 inJAMA Network Open.Therese Jön

Delivery methods compared for osteoarthritis intervention

First-line intervention for hip or knee osteoarthritis (OA) may reduce pain whether delivered in-person or digitally, according to a study published online Nov. 3 inJAMA Network Open.Therese Jön
Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther
How changing gut microbiota can affect lupus disease activity in mice

How changing gut microbiota can affect lupus disease activity in mice

by The Ohio State UniversityFigure 1. NZM2410 colonized with SFB exhibit intensified kidney disease with elevated immune-complex deposition. 10-week old mice were oral gavaged with fecal matter f

How changing gut microbiota can affect lupus disease activity in mice

by The Ohio State UniversityFigure 1. NZM2410 colonized with SFB exhibit intensified kidney disease with elevated immune-complex deposition. 10-week old mice were oral gavaged with fecal matter f